Fungisiso yeStock yeAllogene Therapeutics (ALLO)
Allogene Therapeutics
AI forecast: ALLO
AI inoburitsa mutengo wechinangwa wezuva rinotevera rekutengesa, mugumo wevhiki uye mugumo wemwedzi. Shanduko inoyerwa kubva pamutengo wekupedzisira. Izvi zvinongova zvifungisiso zvehutano, hazviri mazano ekudyara.
Price over the last 6 months
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nzira yekufungisisa
Nzira yekufungisisa — yese fungisiso yekare pamwe chete nekukwira kwazvino — ndiyo Premium.
Unlock PremiumNdiyi ya Kompani Iyi
Allogene Therapeutics, Inc. is a biotechnology company that develops T-cell therapies using allogeneic chimeric antigen receptors for the treatment of blood cancers and solid tumors. Allogene Therapeutics serves patients in California.